CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-06 | Hoenlein Malcolm Director | Purchase | +25,000 | $1.61 | $40K | 55,000 |
| 2014-11-06 | ROSENWALD LINDSAY A MD President and CEO | Purchase | +150,000 | $1.61 | $242K | 4,790,347 |
| 2014-06-02 | Lu Lucy Chief Financial Officer | Purchase | +5,000 | $1.37 | $7K | 30,631 |
| 2014-04-22 | HORGAN KEVIN Former Chief Medical Officer | Exercise or conversion | +47,566 | $1.71 | $81K | 47,566 |
| 2014-04-22 | HORGAN KEVIN Former Chief Medical Officer | Sale | −47,566 | $1.89 | $90K | 0 |
| 2014-04-22 | HORGAN KEVIN Former Chief Medical Officer | Exercise or conversion · Options to purchase Common Stock | −47,566 | 0 | ||
| 2014-04-21 | HORGAN KEVIN Former Chief Medical Officer | Exercise or conversion | +19,000 | $1.71 | $32K | 19,000 |
| 2014-04-21 | HORGAN KEVIN Former Chief Medical Officer | Sale | −19,000 | $1.81 | $34K | 0 |
| 2014-04-21 | HORGAN KEVIN Former Chief Medical Officer | Exercise or conversion · Options to purchase Common Stock | −19,000 | 47,566 | ||
| 2014-04-17 | HORGAN KEVIN Former Chief Medical Officer | Exercise or conversion | +101 | $1.71 | $173 | 101 |
| 2014-04-17 | HORGAN KEVIN Former Chief Medical Officer | Sale | −101 | $1.85 | $187 | 0 |
| 2014-04-17 | HORGAN KEVIN Former Chief Medical Officer | Exercise or conversion · Options to purchase Common Stock | −101 | 66,566 | ||
| 2014-02-20 | BARRETT DAVID JONATHAN Director | Grant or award | +50,000 | 50,000 | ||
| 2014-02-20 | Harvey Jimmie Director | Grant or award | +50,000 | 50,000 | ||
| 2014-02-20 | LOBELL J JAY Director | Grant or award | +50,000 | 386,000 | ||
| 2014-02-20 | Rowinsky Eric K Director | Grant or award | +50,000 | 50,000 | ||
| 2014-02-20 | WEISS MICHAEL S Exec. VC - Strategic Dev. | Grant or award | +3,958,692 | 5,938,038 | ||
| 2014-02-20 | Hoenlein Malcolm Director | Grant or award | +30,000 | 30,000 | ||
| 2013-12-19 | LOBELL J JAY Director | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 | ||
| 2013-12-19 | Rowinsky Eric K Director | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 |
Page 11 of 12 · 231 trades